Analysts’ ratings for Tandem Diabetes Care (NASDAQ:TNDM) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $50.57, along with a high estimate of $58.00 and a low estimate of $39.00. Marking an increase of 7.14%, the current average surpasses the previous average price target of $47.20. Investiga…